Concepedia

Lilly Wong

LW

Statistics

Publications

34

Citations

1.4K

H-Index

21

Active since

1992

Affiliations

University of California San Diego(Current)

Sarah Cannon

Fate Therapeutics (United States)

The University of Texas MD Anderson Cancer Center

University of North Carolina at Chapel Hill

Lilly Wong is an author at University of California San Diego specializing in life sciences, oncology, and molecular biology.

ORCID

Publications per year

1992–2025

34

Publications

34

Brain microglia serve as a persistent HIV reservoir despite durable antiretroviral therapy

Yuyang Tang, Antoine Chaillon, Sara Gianella et al. · Journal of Clinical Investigation · 2023 · 146 citations · Full text

, , +16

Mechanism of Oxime Reactivation of Acetylcholinesterase Analyzed by Chirality and Mutagenesis

Lilly Wong, Zoran Radić, Roger J. M. Brüggemann et al. · Biochemistry · 2000 · 115 citations

, , +17

Induced pluripotent stem-cell-derived CD19-directed chimeric antigen receptor natural killer cells in B-cell lymphoma: a phase 1, first-in-human trial

Armin Ghobadi, Veronika Bachanová, Krish Patel et al. · The Lancet · 2025 · 113 citations · Full text

, , +16

Mezigdomide plus Dexamethasone in Relapsed and Refractory Multiple Myeloma

Paul G. Richardson, Suzanne Trudel, Rakesh Popat et al. · New England Journal of Medicine · 2023 · 85 citations · Full text

, , +16

Safety and Efficacy of FT596, a First-in-Class, Multi-Antigen Targeted, Off-the-Shelf, iPSC-Derived CD19 CAR NK Cell Therapy in Relapsed/Refractory B-Cell Lymphoma

Veronika Bachanová, Armin Ghobadi, Krish Patel et al. · Blood · 2021 · 82 citations

, , +14

1–5 of 34